CYTOSORBENTS CORPORATION Research and Development Expense
CYTOSORBENTS CORPORATION (CTSO) reported Research and Development Expense of $1.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- CYTOSORBENTS CORPORATION research and development expense for the quarter ending 2026-06-30 was $1.45M, a 15.13% increase year-over-year.
- CYTOSORBENTS CORPORATION research and development expense for the quarter ending 2026-03-31 was $1.02M, a 38.36% decline year-over-year.
- CYTOSORBENTS CORPORATION research and development expense for the quarter ending 2025-06-30 was $1.26M, a 16.95% decline year-over-year.
- CYTOSORBENTS CORPORATION research and development expense for the quarter ending 2025-03-31 was $1.66M, a 26.03% decline year-over-year.
- CYTOSORBENTS CORPORATION research and development expense for fiscal 2023 was $15.73M, a 4.03% increase from fiscal 2022.
- CYTOSORBENTS CORPORATION research and development expense for fiscal 2022 was $15.12M, a 7.70% decline from fiscal 2021.
- CYTOSORBENTS CORPORATION research and development expense for fiscal 2021 was $16.38M, a 85.92% increase from fiscal 2020.
- CYTOSORBENTS CORPORATION research and development expense for fiscal 2020 was $8.81M, a 27.14% decline from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 173 month | Research and Development Expense 176 month | Research and Development Expense 179 month | Research and Development Expense 182 month | Research and Development Expense 185 month | Research and Development Expense 188 month | Research and Development Expense 191 month | Research and Development Expense 194 month | Research and Development Expense 197 month | Research and Development Expense 200 month | Research and Development Expense 203 month | Research and Development Expense 206 month | Research and Development Expense 209 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.45M 10-Q · filed 2026-08-06 | $2.48M 10-Q · filed 2026-08-06 | |||||||||||||||||||
| 2026-03-31 | $1.02M 10-Q · filed 2026-05-13 | ||||||||||||||||||||
| 2025-06-30 | $1.26M 10-Q · filed 2026-08-06 | $2.92M 10-Q · filed 2026-08-06 | |||||||||||||||||||
| 2025-03-31 | $1.66M 10-Q · filed 2026-05-13 | ||||||||||||||||||||
| 2024-09-30 | $1.85M 10-Q · filed 2024-11-07 | $3.37M derived: sum of 2 quarters · filed 2024-11-07 | $5.62M 10-Q · filed 2024-11-07 | $9.72M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||||||||
| 2024-06-30 | $1.52M 10-Q · filed 2024-08-13 | $3.77M 10-Q · filed 2024-08-13 | $7.86M derived: sum of 3 quarters · filed 2024-08-13 | $11.61M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||||||||
| 2024-03-31 | $2.25M 10-Q · filed 2024-05-09 | $6.34M derived: sum of 2 quarters · filed 2024-05-09 | $10.09M derived: sum of 3 quarters · filed 2024-11-07 | $13.76M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||||||||
| 2023-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $7.85M derived: sum of 2 quarters · filed 2024-11-07 | $11.51M derived: sum of 3 quarters · filed 2024-11-07 | $15.73M 10-K · filed 2024-03-15 | |||||||||||||||||
| 2023-09-30 | $3.75M 10-Q · filed 2024-11-07 | $7.42M derived: sum of 2 quarters · filed 2024-11-07 | $11.63M 10-Q · filed 2024-11-07 | $15.03M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||||||||
| 2023-06-30 | $3.67M 10-Q · filed 2024-08-13 | $7.88M 10-Q · filed 2024-08-13 | $11.29M derived: sum of 3 quarters · filed 2024-08-13 | $14.58M derived: sum of 4 quarters · filed 2024-08-13 | |||||||||||||||||
| 2023-03-31 | $4.21M 10-Q · filed 2024-05-09 | $7.62M derived: sum of 2 quarters · filed 2024-05-09 | $10.91M derived: sum of 3 quarters · filed 2024-05-09 | $15.09M derived: sum of 4 quarters · filed 2024-05-09 | |||||||||||||||||
| 2022-12-31 | $3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $6.69M derived: sum of 2 quarters · filed 2024-03-15 | $10.88M derived: sum of 3 quarters · filed 2024-03-15 | $15.12M 10-K · filed 2024-03-15 | |||||||||||||||||
| 2022-09-30 | $3.29M 10-Q · filed 2023-11-09 | $7.47M derived: sum of 2 quarters · filed 2023-11-09 | $11.72M 10-Q · filed 2023-11-09 | $17.85M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||||||||
| 2022-06-30 | $4.18M 10-Q · filed 2023-08-01 | $8.43M 10-Q · filed 2023-08-01 | $14.56M derived: sum of 3 quarters · filed 2024-03-15 | $18.83M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||||||||
| 2022-03-31 | $4.24M 10-Q · filed 2023-05-02 | $10.38M derived: sum of 2 quarters · filed 2024-03-15 | $14.64M derived: sum of 3 quarters · filed 2024-03-15 | $18.34M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||||||||
| 2021-12-31 | $6.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $10.40M derived: sum of 2 quarters · filed 2024-03-15 | $14.10M derived: sum of 3 quarters · filed 2024-03-15 | $16.38M 10-K · filed 2024-03-15 | |||||||||||||||||
| 2021-09-30 | $4.26M 10-Q · filed 2022-11-03 | $7.96M derived: sum of 2 quarters · filed 2022-11-03 | $10.24M 10-Q · filed 2022-11-03 | $12.93M derived: sum of 4 quarters · filed 2023-03-09 | |||||||||||||||||
| 2021-06-30 | $3.70M 10-Q · filed 2022-08-02 | $5.98M 10-Q · filed 2022-08-02 | $8.67M derived: sum of 3 quarters · filed 2023-03-09 | $10.42M derived: sum of 4 quarters · filed 2023-03-09 | |||||||||||||||||
| 2021-03-31 | $2.28M 10-Q · filed 2022-05-03 | $4.97M derived: sum of 2 quarters · filed 2023-03-09 | $6.72M derived: sum of 3 quarters · filed 2023-03-09 | $9.13M derived: sum of 4 quarters · filed 2023-03-09 | |||||||||||||||||
| 2020-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $4.44M derived: sum of 2 quarters · filed 2023-03-09 | $6.85M derived: sum of 3 quarters · filed 2023-03-09 | $8.81M 10-K · filed 2023-03-09 | |||||||||||||||||
| 2020-09-30 | $1.75M 10-Q · filed 2021-11-04 | $4.16M derived: sum of 2 quarters · filed 2021-11-04 | $6.12M 10-Q · filed 2021-11-04 | $9.68M derived: sum of 4 quarters · filed 2022-03-10 | |||||||||||||||||
| 2020-06-30 | $2.41M 10-Q · filed 2021-08-03 | $4.37M 10-Q · filed 2021-08-03 | $7.93M derived: sum of 3 quarters · filed 2022-03-10 | $11.11M derived: sum of 4 quarters · filed 2022-03-10 | |||||||||||||||||
| 2020-03-31 | $1.97M 10-Q · filed 2021-05-04 | $5.52M derived: sum of 2 quarters · filed 2022-03-10 | $8.71M derived: sum of 3 quarters · filed 2022-03-10 | $11.64M derived: sum of 4 quarters · filed 2022-03-10 | |||||||||||||||||
| 2019-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $6.74M derived: sum of 2 quarters · filed 2022-03-10 | $9.67M derived: sum of 3 quarters · filed 2022-03-10 | $12.09M 10-K · filed 2022-03-10 | |||||||||||||||||
| 2019-09-30 | $3.19M 10-Q · filed 2020-11-04 | $6.11M derived: sum of 2 quarters · filed 2020-11-04 | $8.53M 10-Q · filed 2020-11-04 | $10.96M derived: sum of 4 quarters · filed 2021-03-09 | |||||||||||||||||
| 2019-06-30 | $2.93M 10-Q · filed 2020-08-04 | $5.35M 10-Q · filed 2020-08-04 | $7.77M derived: sum of 3 quarters · filed 2021-03-09 | $9.72M derived: sum of 4 quarters · filed 2021-03-09 | |||||||||||||||||
| 2019-03-31 | $2.42M 10-Q · filed 2020-05-05 | $4.84M derived: sum of 2 quarters · filed 2021-03-09 | $6.79M derived: sum of 3 quarters · filed 2021-03-09 | $8.36M derived: sum of 4 quarters · filed 2021-03-09 | |||||||||||||||||
| 2018-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $4.37M derived: sum of 2 quarters · filed 2021-03-09 | $5.94M derived: sum of 3 quarters · filed 2021-03-09 | $7.72M 10-K · filed 2021-03-09 | |||||||||||||||||
| 2018-09-30 | $1.94M 10-Q · filed 2019-11-05 | $3.52M derived: sum of 2 quarters · filed 2019-11-05 | $5.30M 10-Q · filed 2019-11-05 | $6.91M derived: sum of 4 quarters · filed 2020-03-05 | |||||||||||||||||
| 2018-06-30 | $1.58M 10-Q · filed 2019-08-06 | $3.36M 10-Q · filed 2019-08-06 | $4.97M derived: sum of 3 quarters · filed 2020-03-05 | $5.61M derived: sum of 4 quarters · filed 2020-03-05 | |||||||||||||||||
| 2018-03-31 | $1.73M 10-Q · filed 2019-05-07 | $1.78M 10-Q · filed 2018-05-08 | $3.39M derived: sum of 2 quarters · filed 2020-03-05 | $4.03M derived: sum of 3 quarters · filed 2020-03-05 | $4.49M derived: sum of 4 quarters · filed 2020-03-05 | ||||||||||||||||
| 2017-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $2.31M derived: sum of 2 quarters · filed 2020-03-05 | $2.77M derived: sum of 3 quarters · filed 2020-03-05 | $3.22M 10-K · filed 2020-03-05 | $4.05M 10-K · filed 2018-03-08 | ||||||||||||||||
| 2017-09-30 | $643.19K 10-Q · filed 2018-11-06 | $537.95K 10-Q · filed 2017-11-09 | $1.10M derived: sum of 2 quarters · filed 2018-11-06 | $1.56M 10-Q · filed 2018-11-06 | $1.63M 10-Q · filed 2017-11-09 | $2.52M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||||
| 2017-06-30 | $458.03K 10-Q · filed 2018-08-02 | $487.61K 10-Q · filed 2017-08-07 | $912.30K 10-Q · filed 2018-08-02 | $957.16K 10-Q · filed 2017-08-07 | $1.88M derived: sum of 3 quarters · filed 2019-03-07 | $3.05M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||||
| 2017-03-31 | $469.55K 10-Q · filed 2018-05-08 | $1.42M derived: sum of 2 quarters · filed 2019-03-07 | $2.59M derived: sum of 3 quarters · filed 2019-03-07 | $3.69M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||||||
| 2016-12-31 | $952.75K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $2.12M derived: sum of 2 quarters · filed 2019-03-07 | $3.22M derived: sum of 3 quarters · filed 2019-03-07 | $4.07M 10-K · filed 2019-03-07 | $4.78M 10-K · filed 2017-03-03 | ||||||||||||||||
| 2016-09-30 | $1.17M 10-Q · filed 2017-11-09 | $2.26M derived: sum of 2 quarters · filed 2017-11-09 | $3.12M 10-Q · filed 2017-11-09 | $4.37M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||||||||
| 2016-06-30 | $1.09M 10-Q · filed 2017-08-07 | $1.95M 10-Q · filed 2017-08-07 | $3.20M derived: sum of 3 quarters · filed 2018-03-08 | $4.07M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||||||||
| 2016-03-31 | $856.12K 10-Q · filed 2017-05-08 | $2.11M derived: sum of 2 quarters · filed 2018-03-08 | $2.97M derived: sum of 3 quarters · filed 2018-03-08 | $3.78M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||||||||
| 2015-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $2.12M derived: sum of 2 quarters · filed 2018-03-08 | $2.92M derived: sum of 3 quarters · filed 2018-03-08 | $3.87M 10-K · filed 2018-03-08 | |||||||||||||||||
| 2015-09-30 | $866.33K 10-Q · filed 2016-11-07 | $1.67M derived: sum of 2 quarters · filed 2016-11-07 | $2.62M 10-Q · filed 2016-11-07 | $3.59M derived: sum of 4 quarters · filed 2017-03-03 | |||||||||||||||||
| 2015-06-30 | $801.66K 10-Q · filed 2016-08-09 | $1.75M 10-Q · filed 2016-08-09 | $2.72M derived: sum of 3 quarters · filed 2017-03-03 | $3.60M derived: sum of 4 quarters · filed 2017-03-03 | |||||||||||||||||
| 2015-03-31 | $951.03K 10-Q · filed 2016-05-09 | $1.92M derived: sum of 2 quarters · filed 2017-03-03 | $2.80M derived: sum of 3 quarters · filed 2017-03-03 | $3.15M derived: sum of 4 quarters · filed 2017-03-03 | |||||||||||||||||
| 2014-12-31 | $967.70K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $1.85M derived: sum of 2 quarters · filed 2017-03-03 | $2.19M derived: sum of 3 quarters · filed 2017-03-03 | $2.43M 10-K · filed 2017-03-03 | |||||||||||||||||
| 2014-09-30 | $880.29K 10-Q · filed 2015-11-13 | $1.23M derived: sum of 2 quarters · filed 2015-11-13 | $1.46M 10-Q · filed 2015-11-13 | $1.50M derived: sum of 4 quarters · filed 2015-11-13 | |||||||||||||||||
| 2014-06-30 | $346.99K 10-Q · filed 2015-08-13 | $583.77K 10-Q · filed 2015-08-13 | $616.21K derived: sum of 3 quarters · filed 2015-08-13 | $910.40K derived: sum of 4 quarters · filed 2015-08-13 | $56.25M 10-Q · filed 2014-08-12 | ||||||||||||||||
| 2014-03-31 | $236.77K 10-Q · filed 2015-05-11 | $269.21K derived: sum of 2 quarters · filed 2015-05-11 | $563.41K derived: sum of 3 quarters · filed 2015-05-11 | $1.27M derived: sum of 4 quarters · filed 2015-05-11 | $55.91M 10-Q · filed 2014-05-14 | ||||||||||||||||
| 2013-12-31 | $32.44K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $326.64K derived: sum of 2 quarters · filed 2015-03-31 | $1.03M derived: sum of 3 quarters · filed 2015-03-31 | $1.74M 10-K · filed 2015-03-31 | $55.67M 10-K · filed 2014-03-31 | ||||||||||||||||
| 2013-09-30 | $294.20K 10-Q · filed 2014-11-12 | $1.00M derived: sum of 2 quarters · filed 2014-11-12 | $1.71M 10-Q · filed 2014-11-12 | $2.38M derived: sum of 4 quarters · filed 2014-11-12 | $55.64M 10-Q · filed 2013-11-06 | ||||||||||||||||
| 2013-06-30 | $708.16K 10-Q · filed 2014-08-12 | $1.41M 10-Q · filed 2014-08-12 | $2.09M derived: sum of 3 quarters · filed 2014-08-12 | $2.64M derived: sum of 4 quarters · filed 2014-08-12 | $55.34M 10-Q · filed 2013-08-14 | ||||||||||||||||
| 2013-03-31 | $704.14K 10-Q · filed 2014-05-14 | $1.38M derived: sum of 2 quarters · filed 2014-05-14 | $1.94M derived: sum of 3 quarters · filed 2014-05-14 | $2.65M derived: sum of 4 quarters · filed 2014-05-14 | $54.63M 10-Q · filed 2013-05-15 | ||||||||||||||||
| 2012-12-31 | $678.08K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.23M derived: sum of 2 quarters · filed 2014-03-31 | $1.95M derived: sum of 3 quarters · filed 2014-03-31 | $2.53M 10-K · filed 2014-03-31 | $53.93M 10-K · filed 2013-04-03 | ||||||||||||||||
| 2012-09-30 | $554.27K 10-Q · filed 2013-11-06 | $1.27M derived: sum of 2 quarters · filed 2013-11-06 | $1.85M 10-Q · filed 2013-11-06 | $2.40M derived: sum of 4 quarters · filed 2013-11-06 | $53.31M 10-Q · filed 2012-11-21 | ||||||||||||||||
| 2012-06-30 | $715.75K 10-Q · filed 2013-08-14 | $665.75K 10-Q · filed 2012-08-13 | $1.39M 10-Q · filed 2013-08-14 | $1.31M 10-Q · filed 2012-08-13 | $1.84M derived: sum of 3 quarters · filed 2013-08-14 | $2.62M derived: sum of 4 quarters · filed 2013-08-14 | $52.21M 10-Q · filed 2012-08-13 | ||||||||||||||
| 2012-03-31 | $632.85K 10-Q · filed 2013-05-15 | $643.28K 10-Q · filed 2012-05-15 | $1.13M derived: sum of 2 quarters · filed 2013-05-15 | $1.91M derived: sum of 3 quarters · filed 2013-05-15 | $2.76M derived: sum of 4 quarters · filed 2013-05-15 | $51.54M 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $494.67K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-03 | $1.27M derived: sum of 2 quarters · filed 2013-04-03 | $2.13M derived: sum of 3 quarters · filed 2013-04-03 | $2.89M 10-K · filed 2013-04-03 | $50.90M 10-K · filed 2012-03-30 | ||||||||||||||||
| 2011-09-30 | $779.59K 10-Q · filed 2012-11-21 | $1.63M derived: sum of 2 quarters · filed 2012-11-21 | $2.39M 10-Q · filed 2012-11-21 | $2.59M derived: sum of 4 quarters · filed 2012-11-21 | $50.40M 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2011-06-30 | $854.83K 10-Q · filed 2012-08-13 | $1.61M 10-Q · filed 2012-08-13 | $1.81M derived: sum of 3 quarters · filed 2012-08-13 | $2.34M derived: sum of 4 quarters · filed 2012-08-13 | $49.63M 10-Q · filed 2011-08-15 | ||||||||||||||||
| 2011-03-31 | $759.16K 10-Q · filed 2012-05-15 | $956.38K derived: sum of 2 quarters · filed 2012-05-15 | $1.48M derived: sum of 3 quarters · filed 2012-05-15 | $1.84M derived: sum of 4 quarters · filed 2012-05-15 | |||||||||||||||||
| 2010-12-31 | $197.22K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $723.27K derived: sum of 2 quarters · filed 2012-03-30 | $1.08M derived: sum of 3 quarters · filed 2012-03-30 | $1.76M 10-K · filed 2012-03-30 | |||||||||||||||||
| 2010-09-30 | $526.04K 10-Q · filed 2011-11-14 | $878.93K derived: sum of 2 quarters · filed 2011-11-14 | $1.56M 10-Q · filed 2011-11-14 | ||||||||||||||||||
| 2010-06-30 | $352.89K 10-Q · filed 2011-08-15 | $1.03M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |